Abstract-This review is devoted to the analysis of probable participation of small heat shock proteins in dif ferent cellular processes of diabetes. Diabetes causes metabolic stress that is accompanied by change of car bohydrate metabolism, accumulation of products of glycation and glycosylation, modulation of protein kinase activity, modulation of redox state of the cell and increase of reactive oxygen species. All these pro cesses can increase expression of small heat shock proteins. Therefore, diabetes increases the level of small heat shock proteins in the heart and retina and certain brain regions and in the kidney cells. Increase of the level of small heat shock proteins can improve transduction of insulin signal and protect the cell against oxi dative stress and apoptosis. Different ways providing increase of the level of small heat shock proteins are ana lyzed. Different mechanisms of covalent modification of proteins by carbohydrates and their metabolites are described. Data are presented that indicate that hyperglycemia induces modification of different amino acid residues. This leads to the changes in the structure, chemical crosslinking, and modulation of physiologically important properties of the small heat shock proteins. Further detailed investigation of small heat shock pro teins might be important for utilization of these proteins as a promising potential target for development of new approaches for treatment of different forms of diabetes.
1 Diabetes is a widespread, dangerous disease lead ing to multiple damages of vessels and many internal organs [1] . Diabetes can be caused either by insuffi cient synthesis of insulin (diabetes of the first type) or insensitivity of target organs to insulin (diabetes of the second type). Both processes result in decreased abil ity of organs to utilize glucose from the blood stream leading to hyperglycemia. It is supposed that hypergly cemia affects at least five different interconnected pro cesses, namely, polyol pathway flux of carbohydrates, accumulation of advanced glycation end products (AGE), activation of polyfunctional protein kinase C, glycosylation of different regulatory proteins and tran scription factors and, finally, increased level of reactive oxygen species (ROS) [2] . Each of these processes affects many different proteins and enzymes and, since they are very complicated, they cannot be ana lyzed in detail in this minireview. However, each of these processes disturbs homeostasis and leads to cell stress. This review is devoted to analysis of the mecha nism of functioning of small heat shock proteins (sHsp) under conditions induced by hyperglycemia.
Small heat shock proteins form a large family com bining proteins that contain conservative α crystallin domain in their structure [3] . The monomers of these proteins have rather small molecular weight and tend to form large homo or heterooligo 1 The article was translated by the authors. meric complexes [3, 4] . Ten different small heat shock proteins (HspB1-HspB10) are expressed in different human tissues. These proteins prevent accumulation of improperly folded or partially denatured proteins, stabilize cytoskeleton, participate in regulation of redox state, possess antiapoptotic activity, and per form many other functions directed predominantly in keeping cellular homeostasis and elimination of con sequences caused by different stresses. Let us analyze the role of sHsp in diabetes.
There are rather controversial data on the level of sHsp and autoantibodies to these proteins in serum of diabetics of the first and the second type. In the inves tigation performed on a rather large cohort of diabetics of the first type, it was found that diabetes is accompa nied by increased level of HspB1 in serum and it was concluded that this protein can be used as a marker of diabetic neuropathy [5] . At the same time, the attempt to utilize auto HspB1 antibodies as the marker of vas cular complication caused by diabetes of the first type was unsuccessful [6] . However, it was found that the patients with glucose intolerance and cardio vascular diseases have higher level of HspB1 than the control group of patients with only glucose intolerance [7] . It is hypothesized that HspB1 is translocated to the blood from tissues where diabetes of the first type induces increased synthesis of this protein. Increased level of HspB1 in serum can induce autoimmune reac tion and this leads to increased level of auto HspB1 antibodies in serum. These antibodies can penetrate neurons, thus leading to apoptosis causing symptoms characteristic to different types of neuropathy [8] .
Completely different results were obtained in another investigation performed on patients with the second type of diabetes. In this case, the level of HspB1 in the blood of diabetics was lower than in the case of healthy persons [9] . There are different explanations for this discrepancy. For instance, one cannot exclude that the mechanisms underlying regulation of expression and liberation of HspB1 are different in the case of diabetes of the first and of the second type. Moreover, the pres ence of auto HspB1 antibodies makes exact determi nation of HspB1 in serum very complicated.
It is assumed that diabetes causes decrease of the level of certain heat shock proteins, such as Hsp70 (Hsp72) and heme oxygenase (Hsp32), in the insulin sensitive organs (skeletal muscle, heart, liver, mono cytes) [10] . At the same time, streptozotocin induced (STZ induced) diabetes was accompanied by increased level of HspB2, HspB3, and HspB5 (αB crystallin) without changes of HspB1 expression and decreased level of HspB6 in the heart [11] . Similar changes of the level of small heat shock proteins were detected in the case of STZ induced diabetes in the retina and crystal line lens. In this case, expression of two crystallins (αA and αB crystallins, HspB4 and HspB5, respec tively) and HspB8 was increased, whereas expression of HspB1 remained unchanged, and expression of HspB6 was decreased [12, 13] . Similar changes of all crystallin types were detected in the retina of Ins2Akita mouse line, which models diabetes of the first type, and in Stz induced diabetes [14] . It was shown that, in the case of diabetes of the first type, increased level of α crystallins improves cell survival. However, under condition of diabetes, expressed crystalline undergoes different posttranslational modifications and this decreases its interaction with proapoptotic protein Bax and, therefore, even increased expression of crys tallins cannot prevent retina cell apoptosis [14] .
Stz induced diabetes is accompanied by significant increase of HspB1 in hippocampus [15] . It is assumed that the oxidative stress is the main signal inducing increased expression of HspB1 [15] and that increased HspB1 expression protects hippocampus cells from apoptosis [16] .
Analogous results were obtained in the case of kid ney cells. Incubation of kidney slices or isolated podocytes in the medium with increased glucose con centration, as well as experiments with rats with Stz induced diabetes, indicate increased expression of HspB1 [17, 18] . In another investigation performed on podocytes cultured in high glucose media or on rats with STZ induced diabetes, increased expression of HspB1 was not detected. However, in this case, the level of HspB1 phosphorylation was significantly increased [19] . It is worthwhile to mention that these changes in HspB1 phosphorylation were detected only in the early stages of diabetes. In the later stages of dia betes, HspB1 phosphorylation returned to its initial level and this was accompanied by albuminuria signal ing that all compensatory mechanisms of the organism are exhausted and symptoms of diabetic nephropathy start to appear [19] . The data presented might indicate that HspB1 and, probably, its phosphorylated forms participate in protection of kidney cells from apoptosis induced by high glucose media and/or participate in stabilization of cytoskeleton and, therefore, can be involved in protection of kidney from diabetic nephr opathy [17] .
Diabetes and hyperglycemia are accompanied by the changes of the level of phosphorylation of certain sites of crystallin and HspB1 and translocation of small heat shock proteins from cytosol to cytoskeleton or to the fraction of insoluble proteins [11, 12, 14, 17] . This can be due to different reasons. For instance, under stress conditions, sHsp interact with damaged or partially denatured proteins and form either large oligomeric complexes or translocate on the damaged elements of cytoskeleton. In addition, diabetes can induce chemical modification and protein crosslink ing by different products, which are formed in carbo hydrate metabolism. As a result of all these events, the small heat shock proteins are oversaturated by protein substrates and, therefore, the concentration of free sHsp is decreased and they become unable to perform control over other vital cellular processes like apopto sis or redox state of the cell. Therefore, it is hypothe sized that increase of sHsp level can improve the state of diabetics [10, 20, 21] . This can be due to different reasons. Firstly, small heat shock proteins interact and inhibit activity of two protein kinases (JNK and IKKβ), which are able to phosphorylate Ser residues of insulin receptor substrate protein (IRS). This phos phorylation inhibits transduction of insulin signal and leads to insulin resistance. Therefore, binding and inhibition of JNK and IKKβ by small heat shock pro teins will improve insulin sensitivity [21] . Secondly, as already mentioned, sHsp play important role in the control of redox state of the cell [22] . Therefore, increased expression of small heat shock proteins leads to protection against reactive oxygen species (ROS) that are considered to be the main inducers of patho logical processes accompanying diabetes. Thirdly, sHsp possess high antiapoptotic activity, which seems to be due to the regulation of certain protein kinases (JNK, PI3K, Akt) and to direct binding of cyto chrome c and proapoptotic protein BAX [4] . There fore, increase of Hsp level provides better survival to the β cells of Langerhans islets under the condition of Stz induced diabetes. [23] . There are several ways of increasing the sHsp level. Under experimental condi tions, the level of sHsp can be increased genetically. SUDNITSYNA, GUSEV protection than motor neurons [24] . The level of small heat shock proteins can be increased by means of hyperthermia of isolated tissues or of the whole body [10] . It was found that even short hyperthermia-15 min and as infrequent as once a week-results in remarkable improvement of metabolic state of patients with diabetes of the second type or obese patients [10] . However, it is worthwhile to mention that the thermal shock of the whole body can differently affect HspB1 level in different tissues. For instance, thermal shock increased the HspB1 level in liver, heart, and kidney of rats with Stz induced diabetes. At the same time, hyperthermia had no effect on HspB1 expression in skeletal muscles [25] . Several chemical compounds able to increase the level of small heat shock proteins are described in the literature. We can mention biofla vonoid naringin [26] , polyphenol resveratrol [27] , as well as curcumin, capsaicin, derivatives of hydroxamic acid, and many other compounds [10] . However, these compounds can differently affect different organs. For instance, resveratrol increases expression of HspB1 in endothelial cells [27] and, at the same time, inhibits HspB1 expression in MCF 7 cells of breast cancer [28] . As already mentioned, hyperglycemia caused by diabetes is accompanied by accumulation of chemi cally modified proteins with properties different from those of unmodified intact proteins. This problem becomes especially important in the case of the eye lens, i.e., in the organ where proteins hardly undergo turnover in the course of the whole life. In the course of aging, chemically modified crystallins are accumu lated in the lens and this is one of the reasons leading to opaqueness and cataracts [29] . At present, many different posttranslational modifications of crystallins are described in the literature and, among them, more than 15 modifications are related to accumulation of the so called advanced glycation end products (AGE) [29, 30] . Being aldehydes or ketones, carbohydrates and, especially, their derivatives (like glyoxal or meth ylglyoxal) can induce nonenzymatic modification of lysine, arginine, histidine, and cysteine and/or induce chemical crosslinking of crystallins [31, 32] . It is obvi ous that, under conditions of hyperglycemia, the effi ciency of glycation is drastically increased and this promotes the process of lens aging and increases the probability of its opacification. Lysine residues located in highly mobile and flexible C terminal (Lys 166, 174, 175 of αB crystallin or Lys 166 of αA crystallin) and N terminal (Lys 11 of αA crystallin) domains of crystallin readily undergo chemical modification [30] . It seems that these modifications do not lead to dra matic changes of the structure and/or chaperone like activity (i.e., ability to prevent aggregation of dena tured proteins) of crystallin [33] . At the same time, selective modification of Lys90 of αB crystallin located in the vicinity of the substrate binding site lead to significant changes of hydrophobic properties and chaperone like activity of this protein [34] . It is worth while to mention that modification is accompanied by formation of a number of different derivatives of lysine (N ε carboxymethyl and N ε carboxyethyl lysine) as well as of imidasolysine derivative (1,3 di(N ε lysine) 4 methyl imidazolium) (figure). The last modifica tion is accompanied by chemical crosslinking of lysine residues belonging to different crystallin monomers (figure). In diabetes, the probability of crystallin crosslinking is significantly increased [35] .
Even more dramatic changes are induced by mod ification of arginine residues of crystallin; α oxalalde hyde methylglyoxal is the product of glucose metabo lism. At a low concentration (10-100 μM), methylg lyoxal modifies certain Arg residues of αA crystallin and HspB1. This modification leads to formation of the so called argpyrimidines (figure) and this modifi cation is accompanied by significant changes of phys icochemical properties and increase of chaperone like activity [36] that modification of specific residues (Arg21, 49, and 103) leads to increase of chaperone like activity of αA crystallin [36, 37] . Further investigations con firmed that, under certain conditions, modification of αA crystallin by methylglyoxal indeed increases chap erone like activity measured in vitro. However, this modification is accompanied by chemical crosslinking of αA crystallin and increased probability of its pro teolytic degradation [38] . It is worthwhile to mention that modification of certain residues by one com pound can affect modification of other residues by another compound and can modify the changes induced by this modification. For instance, modifica tion of Lys residues by acetic aldehyde prevents crosslinking of crystallin induced by methylglyoxal and increases methylglyoxal induced enhancement of chaperone like activity. Moreover, modification by methylglyoxal can increases antiapoptotic activity of crystallin and HspB1 [39] . It is hypothesized that methylglyoxal induced increase of chaperone like and antiapoptotic activity is an evolutionarily evolved mechanism for protection of proteins against meta bolic stress [36] , and this effect can be increased by aspirin, which is able to modify certain residues of lysine and cysteine.
In certain respects, this hypothesis correlates with the data obtained on another small heat shock protein, namely HspB1. It was found that, in certain tissues (endothelial cells, mesangial kidney cells, certain tumors), HspB1 is the main protein undergoing meth ylglyoxal modification [40] [41] [42] [43] . This modification leads to formation of argpyrimidine on the place of Argl88 and is accompanied by stabilization of quater nary structure and increase of antiapoptotic activity of HspB1 [42] . These experimental data correlate with the results obtained on two different forms of human nonsmall cell lung cancer. In the case of squamous cell carcinoma, the level of argpyrimidine was higher than in the case of adenocarcinoma cells. At the same time, caspase activity in squamous cell carcinoma was lower than in the case of adenocarcinoma. Moreover, the cells of squamous carcinoma were more resistant to cisplatin (compound used in oncology) than adeno carcinoma cells [41] . The data presented indicate that methylglyoxal modification increases antiapoptotic activity of HspB1. If this conclusion is correct, then one can put forward a hypothesis as to why certain tumors are often very resistant to different drugs. It is well accepted that the tumor cells use glycolysis as the main source of energy production. Glyoxal and meth ylglyoxal are side products of glycolysis. Accumulation of α oxalaldehydes increases the probability of HspB1 modification and, in this way, increases its antiapop totic activity, preventing death of tumor cells induced by different drugs. This hypothesis needs further veri fication, since it was unexpectedly found that meth ylglyoxal modified HspB1 interacts weaker with cyto chrome c [43] .
Summing up, we might conclude that diabetes dis turbs homeostasis and evokes metabolic stress. This stress leads to accumulation of unusual metabolites, covalent protein modification, modulation of activity of certain regulatory enzymes (such as different pro tein kinases), increase of reactive oxygen species, and changes of many other important parameters. These conditions dramatically increase the role of small heat shock proteins that prevent aggregation of denatured proteins, stabilize cytoskeleton, participate in regula tion of key enzymes, and control redox state, prolifer ation and apoptosis. All these factors make reasonable further detailed investigation of the role played by small heat shock proteins in diabetes and search for the way for control changes of small heat shock protein expression in certain organs and tissues. These investi gations might be important for development of new approaches for the treatment of different forms of dia betes. 
